Document text
Principal Investigator: Anna K Majewska
Organization: UNIVERSITY OF ROCHESTER
Fiscal Year: 2024
Award: $308,995
Funding agency: National Institute of Neurological Disorders and Stroke
Remodeling of cortical networks by visual experience during development relies on rapid changes in synaptic
structure and function. The exquisite specificity of these activity-driven synaptic changes begs the question of
how they are implemented. Surprisingly we have recently shown that microglia, the brain’s immune cells, are
critical in this process. However, only a handful of the microglial mechanisms that contribute to plasticity have
been described. These pathways were initially studied for their roles in neuroinflammatory responses and it is
becoming clear that such mechanisms are also used in microglial function in the healthy brain. Norepinephrine
signaling through microglial adrenergic receptors is known to affect microglial function in pathological settings
but microglial contributions to norepinephrine’s effects on plasticity are as yet unstudied. Adrenergic signaling is
a particularly intriguing candidate as it directly opposes the purinergic signaling pathway in microglia that we
showed to be critical for plasticity, suggesting that adrenergic signaling in microglia could also impact synaptic
remodeling. Additionally, adrenergic signaling modulates global state changes between sleep and wakefulness,
and we have recently discovered that arousal changes microglial dynamics, which are critical to microglia-
synapse interactions. Therefore, in this proposal we will test the hypothesis that norepinpehrine acting through
microglial adrenergic receptors alters microglial function thereby affecting plasticity. To rigorously
investigate how norepinephrine affects physiological microglia, we will first examine how adrenergic signaling
affects microglial dynamics, surveillance and injury response in vivo (Aim1). We will then examine how
adrenergic signaling in microglia affects activity-dependent plasticity in the visual cortex (Aim 2) and the
associated functions of microglia during plasticity (Aim 3). We will use pharmacological approaches to alter
adrenergic signaling while monitoring microglia and visual responses, and we will determine whether effects are
specific to adrenergic signaling in microglia using conditional microglia-specific knock-out of the beta 2
adrenergic receptor (β2 AR) which is expressed at high levels within microglia. These studies will provide
important insight into the molecular mechanisms used by microglia when interacting with synapses which is
critical for understanding how microglia contribute to synaptic plasticity. Because synaptic plasticity is affected
in a large number of neurodevelopmental and neurological disorders, many of which are also associated with
aberrant adrenergic signaling, our work will provide potential targets for intervention to reinstate appropriate
plastic changes and ameliorate symptoms in these diseases.
Terms: <AD dementia><ASD><Adrenergic Agents><Adrenergic Drugs><Adrenergic Receptor><Adrenergics><Adrenoceptors><Affect><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Anesthesia><Anesthesia procedures><Animals><Arousal><Assay><Autism><Autistic Disorder><Behavior><Bioassay><Biological Assay><Brain><Brain Nervous System><CNS plasticity><Catecholamine Receptor><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Communication><Defect><Development><Disease><Disorder><Early Infantile Autism><Encephalon><Epilepsy><Epileptic Seizures><Epileptics><Epinephrine Receptors><Eye Dominance><Hortega cell><Human><Immune><Immunes><Infantile Autism><Intervention><Intervention Strategies><Intracellular Communication and Signaling><Kanner's Syndrome><Knock-out><Knockout><Learning><Levarterenol><Levonorepinephrine><Mediating><Microglia><Modeling><Modern Man><Molecular><Monitor><Morphology><Motility><Nerve Cells><Nerve Unit><Nervous System Diseases><Nervous System Disorder><Neural Cell><Neurocyte><Neurodevelopmental Disorder><Neurologic Disorders><Neurological Development Disorder><Neurological Disorders><Neuromodulator><Neuronal Plasticity><Neurons><Noradrenaline><Norepinephrine><Ocular Dominance><Pathologic><Pathway interactions><Phagocytes><Phagocytic Cell><Physiologic><Physiological><Primary Senile Degenerative Dementia><Process><Role><Seizure Disorder><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Site><Sleep><Specificity><Structure><Synapses><Synaptic><Synaptic Cleft><Synaptic plasticity><Testing><Visual><Visual Cortex><Wakefulness><Work><adenoreceptor><alleviate symptom><amebocyte><ameliorating symptom><autism spectral disorder><autism spectrum disorder><autistic spectrum disorder><awake><beta-2 Adrenergic Receptors><biological signal transduction><brain circuitry><central nervous system plasticity><conditional knock-out><conditional knockout><critical period><decrease symptom><developmental><epilepsia><epileptogenic><experience><experiment><experimental research><experimental study><experiments><fewer symptoms><gitter cell><in vivo><in vivo two-photon imaging><injury response><insight><interventional strategy><mesoglia><microglial cell><microgliocyte><neural inflammation><neural plasticity><neurodevelopmental disease><neuroinflammation><neuroinflammatory><neurological disease><neuronal><neuroplastic><neuroplasticity><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><optogenetics><pathway><perivascular glial cell><pharmacologic><primary degenerative dementia><reduce symptoms><relieves symptoms><response><response to injury><senile dementia of the Alzheimer type><social role><symptom alleviation><symptom reduction><symptom relief><synapse><visual cortical><β-2 Adrenoceptor><β2 Adrenergic Receptor>